United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
| Descriptor ID |
D014486
|
| MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 3 | 4 |
| 2009 | 0 | 4 | 4 |
| 2010 | 2 | 11 | 13 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 8 | 8 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 5 | 6 |
| 2015 | 0 | 5 | 5 |
| 2016 | 2 | 5 | 7 |
| 2017 | 1 | 7 | 8 |
| 2018 | 1 | 7 | 8 |
| 2019 | 1 | 6 | 7 |
| 2020 | 2 | 5 | 7 |
| 2021 | 2 | 6 | 8 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 4 | 5 |
| 2025 | 0 | 5 | 5 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Biologics and Novel Therapeutics in Food Allergy. J Allergy Clin Immunol Pract. 2026 Apr; 14(4):762-770.
-
Regulating Medical Devices: The Values and Politics of the US FDA Review Process. J Law Med Ethics. 2026; 54(1):46-57.
-
Estimating risk of reported versus theoretical drug-drug interactions in headaches medicine: an exhaustive comparison between DrugBank and FAERS database for abortive and preventive combinations. J Oral Facial Pain Headache. 2025 Dec; 39(4):165-172.
-
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations. Pharmacotherapy. 2025 Jun; 45(6):367-385.
-
Improving the Infrastructure for Pediatric Medical Device Trials at Children's Hospitals. Pediatrics. 2025 Apr 01; 155(4).
-
Sickle cell disease gene therapy drug expenses and reimbursement: a litmus test for commercial pricing strategy and patient access for curative therapies. Cytotherapy. 2025 May; 27(5):567-570.
-
Supportive Touch in Psychedelic Assisted Therapy. Am J Bioeth. 2025 Jan; 25(1):29-39.
-
Pediatric Device Clinical Trials Activity: 1999-2022. Pediatrics. 2024 Aug 01; 154(2).
-
Syfovre Approval for Geographic Atrophy. JAMA Ophthalmol. 2024 Jul 01; 142(7):685-686.
-
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies. Transplant Cell Ther. 2024 08; 30(8):776-787.